How to Buy Revvity Stock
Revvity Inc
Revvity is a diagnostic & research company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker RVTY on the NYSE exchange.
Revvity stock last closed at $98.50, up 7.95% from the previous day, and has decreased 6.68% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.18 percentage points. Revvity stock is currently +11.27% from its 52-week low of $88.53, and -23.94% from its 52-week high of $129.50.
As of May 12, 2025, there are 117.87M RVTY shares outstanding. The market capitalization of RVTY is $11.61B. In the last 24 hours, 1.64M RVTY shares were traded.
How to Buy Revvity Stock
Wondering how to invest in Revvity stock? Here's how.
- Decide where to buy Revvity stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you decide where to buy Revvity stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Select your method of payment and add your details.
- Analyze Revvity stock: The Revvity ticker symbol is RVTY. Is Revvity stock a good investment? Should you buy shares of RVTY? How do RVTY's underlying business fundamentals look? Do top analysts think Revvity is a good buy? Why has RVTY's stock price moved recently? (Hint: Our stock research tools can help you figure out if RVTY is a good stock to buy).
- Place your RVTY buy order: Decide if you will purchase RVTY shares at the current market price or use a limit order to purchase RVTY stock at a particular price.
- Monitor your investment in RVTY: Create a watchlist to important notifications about your position in Revvity shares.
Step 1: Decide where to buy Revvity stock
You need an online brokerage account to access the NYSE market and buy RVTY stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal details so you are able to buy RVTY stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have finished signing up on the best stock market app, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your new investment account.
Step 4: Analyze Revvity stock
Once you have selected the best place to buy Revvity stock, it's critical to evaluate their stock before you buy, so you truly wrap your head around the risk and opportunity.
Revvity stock at a glance
Fundamentals of RVTY
WallStreetZen was built to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on RVTY's stock page.
What is the fair value of RVTY stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RVTY's true value.
Using relative valuations ratios:
- RVTY may be overvalued based on its P/E ratio of 41.91x, relative to Diagnostics & Research industry P/E ratio of 21.14x
- RVTY could be undervalued based on its P/B ratio of 1.52x, relative to Diagnostics & Research industry P/B ratio of 3.51x
- RVTY could be undervalued based on its PEG ratio of 0.87x
You can do more valuation analysis on RVTY's stock here.
A look at RVTY Cashflows and Balance Sheet
Positive Health Checks:
- RVTY earnings of $365.42M is not sufficient to cover its interest payments.
- RVTY profit margin has gone up from 5.5% to 10.3% in the past year.
- Total RVTY debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the RVTY balance sheet.
Negative Health Checks:
- There are more long-term liabilities than short-term assets on the RVTY balance sheet.
- RVTY's operating cash flow of $608.89M allows it to safely service it's debt of $3.33B.
- RVTY has a relatively high debt to equity ratio of 0.62.
Is Revvity stock a Buy, Hold, or Sell, according to analysts?
Out of 9 Wall Street analysts who research RVTY, the consensus analyst rating on Revvity is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Latest RVTY Analyst Upgrades/Downgrades
Brandon Couillard, a bottom 10% analyst from Wells Fargo maintains RVTY with a hold rating and lowers their RVTY price target from $130.00 to $102.00, on Apr 17, 2025.
Luke Sergott, a bottom 1% analyst from Barclays maintains RVTY with a strong buy rating and lowers their RVTY price target from $140.00 to $110.00, on Apr 10, 2025.
Paul Knight, a top 26% analyst from KeyBanc maintains RVTY with a strong buy rating and raises their RVTY price target from $132.00 to $145.00, on Feb 3, 2025.
KeyBanc's Paul Knight raised their price target on Revvity (NYSE: RVTY) by 9.8% from $132 to $145 on 2025/02/03. The analyst maintained their Strong Buy rating on the stock.
Revvity reported its Q4 and FY 2024 earnings on 2025/01/31.
Since the company pre-announced the results in mid-2025/01, Knight said the focus was on management's FY 2025 guidance and commentary.
The stock was down post-print because management guided a margin reduction in Q1 2025, the analyst said, arguing, however, "that this is being driven by a decision to increase strategic investment."
For its part, Knight continued, KeyBanc believes that reagents, where Revvity has been gaining market share, are one component of the investment - a component with the potential to drive outperformance.
Earnings Report
Revvity reported:
For Q4 2024:
- EPS of $1.42, which beat the Zacks Consensus Estimate of $1.36 and, by 13.6%, Q4 2023’s $1.25.
- Revenue of $729.37M, which missed the Zacks Consensus Estimate by 0.10% but beat, by 5%, Q4 2024’s $695.9M.
For FY 2024:
- EPS of $4.90, up 5.4% Y/Y.
- Revenue of $2.76B, up 0.15% Y/Y.
For FY 2025, management guided:
- EPS of $4.90 to $5.00.
- Revenue of $2.80B to $2.85B.
President & CEO Prahlad Singh commented: “We finished last year on a strong note positioning us well as we head into 2025.
“I am confident that the full potential of Revvity will be even more externally apparent as we move through this year following the significant transformation our business has undergone over the last several years.”
Derik De Bruin, a top 10% analyst from Bank of America upgrades RVTY to a strong buy rating and announces their RVTY price target of $138.00, on Dec 13, 2024.
You can dive deeper into what analysts are saying on the Revvity stock forecast page.
Metrics for Advanced RVTY Traders
RVTY Growth Numbers
Last year, RVTY earnings were $286.61M. During the last 5 year, RVTY's earnings have increased by 2.87% per year. This was slower than the Diagnostics & Research industry average of 9.28%.
Last year, RVTY revenue was $2.77B. During the past five year, RVTY's revenue has increased by -0.83% per year. This was slower than the Diagnostics & Research industry average of 9.67%.
Learn more about RVTY's earnings and revenue performance here.
Who is buying/selling RVTY?
Over the past 12 months, insiders at RVTY have sold more shares than they have bought.
Anita Gonzales, Vice President and Controller of RVTY, was the latest RVTY insider to sell. They sold $5,613.00 worth of RVTY shares on Feb 18, 2025.
Research more about who owns RVTY shares here.
Does RVTY stock generate passive income?
Revvity pays a dividend of 0.21%, compared to the Diagnostics & Research industry's average dividend yield of 0.59%. If you owned $1,000 of RVTY stock, you would have received $2.13 in the past 12 months.
Revvity dividend payments have consistently grown over the past decade and have remained stable.
Get more data about Revvity dividend yield and history here.
What others are saying about RVTY
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your RVTY buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open Trade button and your broker will execute your order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in RVTY
Now that you own some RVTY shares, you'll want to stay up-to-date on your investment.
Put RVTY on a watchlist to keep track of your RVTY stock.
RVTY Feed
How to Buy Stock in Revvity
To summarize, here are the 6 steps you need to take to buy Revvity stock right now:
- Decide where to buy Revvity stock
- Sign up for a brokerage account
- Fund your investment account
- Analyze Revvity stock
- Place your RVTY buy order
- Monitor your investment in RVTY
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your investment in Revvity, create a watchlist on WallStreetZen today.
Other Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.